INVESTOR’S RIGHTS AGREEMENTInvestor's Rights Agreement • September 12th, 2023 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 12th, 2023 Company Industry JurisdictionThis INVESTOR’S RIGHTS AGREEMENT (this “Agreement”), is made as of September 6, 2023, by and between Aptose Biosciences Inc., a Canadian corporation (the “Corporation”), and Hanmi Pharmaceutical Co., Ltd., a corporation incorporated under the laws of the Republic of Korea (the “Investor”).
APTOSE BIOSCIENCES INC. SUBSCRIPTION AGREEMENT common shares INSTRUCTIONSSubscription Agreement • September 12th, 2023 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 12th, 2023 Company Industry Jurisdiction